A Recently Published Analysis May Provide New Guidance on Therapy to Prevent Skeletal-Related Events in Oncology Patients

Results from the analysis of three phase 3 trials suggest that denosumab is superior to zoledronic acid (ZA) in the context of preventing skeletal-related events (SREs) in patients with a history of bone metastasis from various advanced cancers.

Read More

Always Verify Data Entry on Refills

I have heard many pharmacists say they do not verify data entry on refills as intensely as they do for new prescriptions. I have even heard it given as advice to increase speed. Pharmacists that do this reason that it has already been verified by a pharmacist and in some cases multiple pharmacists. Please Do Not follow this advice, at all!

Read More